ArticleOpen medicine (Warsaw, Poland)2025

Serum-derived exomiR-188-3p is a promising novel biomarker for early-stage ovarian cancer.

Mingyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.